Clinical & Regulatory Services
Total Trials
10
As Lead Sponsor
0
As Collaborator
Total Enrollment
480
NCT02674399
A Phase 2 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis
Phase: Phase 2
Role: Collaborator
Start: Feb 16, 2016
Completion: Dec 28, 2018
NCT03482648
First-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers
Phase: Phase 1
Start: Mar 20, 2018
Completion: Oct 3, 2018
NCT03830125
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects
Start: Feb 13, 2019
Completion: Nov 24, 2019
NCT03743623
Neurocytotron on Cerebral Palsy
Phase: N/A
Start: Mar 22, 2019
Completion: Mar 22, 2023
NCT03800420
Efficacy and Safety of BBT-401-1S in Ulcerative Colitis
Start: Apr 22, 2019
Completion: Jul 31, 2020
NCT04138836
Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects
Start: Sep 17, 2019
Completion: Nov 4, 2019
NCT04138849
Evaluate Safety, Pharmacokinetics and Pharmacodynamics of BBT-877 in Healthy Japanese Male
Start: Oct 1, 2019
Completion: Oct 25, 2019
NCT04505839
First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors
Start: Jul 30, 2020
Completion: Mar 7, 2023
NCT04795037
First-In-Human Study of CU06-1004 Following Single and Multiple Ascending Doses in Healthy Volunteers
Start: Jul 15, 2021
Completion: Jun 25, 2022
NCT06704009
NT-101 Topical Ophthalmic Solution in Patients With Wet AMD
Phase: Phase 1/2
Start: Mar 11, 2025
Completion: Dec 24, 2025
Loading map...